NFKB1 and cystic fibrosis: Further investigations into how CF dependent epigenetic changes alter the activity of inflammatory transcription factors such as NFkB and NFAT in response to infection should be carried out to further understand the hyperinflammatory phenotype in CF and for the identification of novel therapeutic targets.